Clinical Trials Directory

Trials / Terminated

TerminatedNCT02026960

RNA Extraction and Amplification From Biopsy Specimens in Subjects With Metastatic Renal Cell Carcinoma (AGS-NTS-017)

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
14 (actual)
Sponsor
Duke University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The primary objective is to evaluate methods for AGS-003 production from surgical (stage I) and metastatic biopsy (stage II) Renal Cell Carcinoma (RCC) and a small subset of other GU cancers (expansion cohort) specimens using core needle biopsy in subjects with RCC or other GU cancers. Specifically, this study will evaluate the feasibility of RNA amplification from total tumor RNA isolated from tissues obtained by core needle tumor biopsy.

Conditions

Interventions

TypeNameDescription
DEVICERNA extraction and amplification from biopsy specimens

Timeline

Start date
2014-03-01
Primary completion
2016-03-01
Completion
2017-09-07
First posted
2014-01-03
Last updated
2018-12-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02026960. Inclusion in this directory is not an endorsement.

RNA Extraction and Amplification From Biopsy Specimens in Subjects With Metastatic Renal Cell Carcinoma (AGS-NTS-017) (NCT02026960) · Clinical Trials Directory